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Abstract The neutrophilic granulocyte (neutrophil) is the
most important cellular component of the innate immune
system. A total absence of neutrophils or a significant
decrease in their number leads to severe immunodeficiency.
A mature neutrophil, released from the bone marrow,
should be able to migrate from the blood towards the
tissues, following a chemotactic gradient to a pathogen. In
order to be neutralized, this pathogen has to be recognized,
phagocytosed, and destroyed by lytic enzymes contained in
the neutrophil's granules and reactive oxygen species
formed by the enzyme complex NADPH oxidase. Rare
genetic defects leading to the loss of each one of these
biological properties of the neutrophil have been described
and are associated with immunodeficiency. This review
provides a summary of the normal development and
biological functions of neutrophils and describes the
diseases caused by defects in neutrophil number and
function.
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Introduction
Fulminant infections in infants and young children are
dramatic events and should be evaluated thoroughly in
countries were hygienic standards have made such diseases
exceptional in children. An unusual severe course of
infection or an unusual pathogen, recurrent pyogenic
infections, and recurrent infections of the upper and lower
respiratory tract may be caused by immunodeficiency due
to an inborn absence or significantly decreased number of
neutrophilic granulocytes (neutrophils) or functional defects
of these cells [9] (Table 1).
Similar to all primary immunodeficiencies, congenital
neutropenia and functional disorders of neutrophils are rare.
The lack of exposure to these diseases for the average
clinician renders it difficult to decide whether a work-up of
neutrophil function ought to be included in the diagnostic
process. This often leads to delay in the diagnosis of these
life-threatening diseases.
In general, a lack of functionally normal neutrophils in
an individual may lead to infections with Staphylococcus
aureus, gram-negative organisms such as Pseudomonas
aeruginosa and Burkholderia cepacia, the gram-positive
bacterium Nocardia asteroides, and infections with fungi
and yeasts such as Aspergillus spp. and Candida spp.
(Fig. 1). In the case of S. aureus, the severity of the disease
or the location of the infection (e.g., liver abscess)
distinguishes an immunocompromised patient from a
healthy individual. The other above-mentioned pathogens,
including fungi, do not cause disease in an immunocompe-
tent child. Hence, once suspected or identified, such
infections should always lead to scrutinizing neutrophil
number and functions.
Immunodeficiencies caused by lack of neutrophils due to
an inborn error are rare, but the initial step in diagnosing
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detected by a routine blood count with differential. When
neutropenia persists and more common causes are exclud-
ed, further work-up can reveal an underlying genetic cause.
Several gene defects have been identified that are respon-
sible for an inadequate maturation of neutrophil precursors
in the bone marrow [27]. Alternatively, in myelokathexis,
the release from the bone marrow of otherwise normally
developed neutrophils is hampered, leading to neutropenia
in the blood and tissues [10].
In recent years, numerous functional defects of neutro-
phils caused by genetic defects have been identified. As cell
counts and standard blood tests are normal in these cases,
the diagnosis is difficult. The suspicion of a functional
defect has to be substantiated by highly specialized tests,
which are expensive and performed in few laboratories, and
is thus not always easily accessible in every country. It is
therefore suspected that many cases remain undiagnosed,
and patients may possibly die without diagnosis, even in
Europe.
Fundamental research over the past decades has led to
increased knowledge on neutrophil biology, in particular
the elucidaton of functional defects. In patients that present
with a clinical phenotype suggestive of a neutrophil defect,
careful analysis will over time reveal other proteins that are
essential for normal neutrophil development and function.
This was recently illustrated by the finding of our group
and others that mutations in FERMT3, the gene encoding
kindlin-3, are responsible for the disease described as
leukocyte adhesion deficiency 1 variant (LAD1 variant) or
LAD3 [18, 22].
As to date, defects in adhesion molecules, essential for
migration of neutrophils, defects in granule formation, and
an inability to undergo a respiratory burst are examples of
well-defined functional disorders of neutrophils. This
article will discuss the most important primary immunode-
ficiencies caused by defective numbers or function of
neutrophils, as compared to the normal biology of these
cells.
Neutrophil development and neutropenia
Neutropenia can be mild (1,000–1,500/μL), moderate
(500–1,000/μL), or severe (<500/μL). Iatrogenic neutrope-
nia dwarfs all other causes. Otherwise, neutropenia is most
frequently caused by auto- or alloantibodies or is associated
with bone marrow depression in the course of viral
infections such as EBV, CMV, or parvovirus. Because
Fig. 1 An ulcerative lesion at the right chest of a formerly healthy 2-
year-old boy. The rare fungus Rhizopus oryzae caused this infection
which led to the diagnosis auosomal recessive chronic granulomatous
disease
Table 1 Most important diseases caused by low numbers or dysfunction of neutrophils
Category Subgroup Diagnosis Treatment
1. Lack of neutrophils
(neutropenia)
Iatrogenic/toxic Effect of cessation of drug
therapy
Removal of toxic agent
Immune mediated Detection of auto- or
alloantibodies
None, usually transient
Infection related Virological tests None, usually transient
Severe congenital neutropenia Bone marrow aspiration G-CSF
Gene analysis Stem cell transplantation
Syndrome associated Genetic counselling Dependent of cause
Dependent of presumed cause
2. Decreased motility Leukocyte adhesion deficiencies
(LAD1, LAD2, LAD1 variant/LAD3)
Functional adhesion tests Stem cell transplantation
Gene analysis
3. Decreased
“danger sensing”
Toll-like receptor deficiencies
(IRAK4 deficiency, MyD88 deficiency)
Functional tests None, mild clinical course from late
childhood on Gene analysis
4. Impaired killing
mechanisms
NADPHoxidase dysfunction
(chronic granulomatous disease)
Functional tests Stem cell transplantation prophylactic
(antibiotics, antifungals, γ-interferon) Gene analysis
Impaired granule formation (Chédiak–Higashi
syndrome, specific granule deficiency)
Microscopic (electron)
evaluation
Stem cell transplantation
Gene analysis
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recover spontaneously. However, these causes may also
lead to persistent neutropenia for a considerable period of
time and should thus be excluded before the exceptional
genetic causes are considered.
Neutrophils mature in the bone marrow in about 2 weeks,
a process in which the myeloid-specific growth factors
granulocyte colony-stimulating factor (G-CSF) and granu-
locyte–monocyte CSF play an important role. In the first
half of this period, the neutrophil precursors differentiate
from myeloblasts through promyelocytes to neutrophilic
myelocytes. In the promyelocyte stage, the azurophil
granules are formed, and the specific granules are formed
in the myelocytic stage. Later stages of neutrophil differ-
entiation comprise metamyelocytes, band forms, and
segmented cells, characterized by the typical appearance
of the nucleus (Fig. 2). Further divisions do not take place
during this period.
Once in the blood, neutrophils are short-living cells with
a circulating half life of 6–8 h. Then, they leave the blood
and move to the tissues, where they live for about two more
days, after which they presumably die by apoptosis. To
maintain equilibrium they are produced at a rate of 5–10×
10
10 a day in the bone marrow. The bone marrow contains
an amount of mature neutrophils 10 times the number of
circulating neutrophils. During infections, release of neu-
trophils and band forms from the marrow is accelerated,
leading to neutrophilia.
The presence of maternal alloantibodies which have
passed the placenta and are directed against epitopes on the
child's neutrophils is a common cause of neutropenia in the
first months of life. Also in early infancy, autoantibodies
against epitopes NA1 and NA2 can lead to destruction of
neutrophil precursors and thus neutropenia. Because of the
often mild and transient course of this disease, it is called
benign neutropenia of infancy (BNC). BNC most often
recovers spontaneously around 3 years of age [6]. Autoanti-
bodies against neutrophil epitopes may also appear in the
course of autoimmune disease.
When neutropenia is present and common causes as
described above are excluded, a first step is bone marrow
aspiration to perform a microscopical examination and a
myeloid cell culture to assess the production, maturation,
and differentiation of neutrophil precursors. Subsequently,
analysis of the most common genes that cause neutropenia
might be performed.
The most common cause for severe congenital neutro-
penia (SCN) are mutations in the gene ELA2 or ELANE [8].
The same gene is affected in cyclic neutropenia in which
severe neutropenia occurs with a relatively strict periodicity
of 3 weeks. There is no clear genotype–phenotype
relationship. We have recently described a multigeneration-
al family with SCN, indicating a clear autosomal dominant
inheritance of the ELANE mutation. This family displayed
considerable variability in the clinical penetrance of
neutropenia [26]. The pathophysiology of ELANE muta-
tions in SCN is not completely understood, but evidence
points towards a role for elastase in maintaining a normal
function of the endoplasmic reticulum (ER) in myeloid
precursor cells, leading to early apoptosis.
The classical form of SCN described by Kostmann
(hence the name “Kostmann's syndrome”) is caused by
autosomal recessive mutations in the HAX1 gene [2, 3].The
Hax-1 protein plays a role in the function of mitochondria
and possibly accelerates apoptosis. Other identified genetic
causes for neutropenia are mutations in CSFR3 (encoding
the G-CSF receptor) and GFI1 (encoding a hematopoietic
transcriptional repressor). Both disorders are autosomal
dominant [17, 27].
Recently, autosomal recessive mutations in the glucose-
6-phosphatase catalytic subunit 3 (G6PC3) gene have
highlighted the importance of glucose homeostasis for the
survival of neutrophils. Patients with G6PC3 deficiency
also suffer from cardiac and urogenital malformations [5].
Recent data from the European Severe Chronic Neutropenia
Registry (SCNER) showed that 56% of patients with SCN
have heterozygous mutations in ELANE, 18% have biallelic
mutations in HAX-1, and 4% show mutations in G6PC3.
Around one third of patients (29%) are genetically
unclassified [17, 27].
Patients with neutropenia frequently present with persis-
tent oral ulcerations, apart from infections with the above-
mentioned microorganisms (Fig. 3). Severe neutropenic
patients can be treated with G-CSF to reduce the number of
infections and increase survival. Unfortunately, long-term
treatment with recombinant G-CSF is associated with an
increased incidence of leukemia. It has been suggested that
the increase in leukemia may be due to the G-CSF
treatment. However, it now appears more likely to be due
to the increased survival of preleukemic patients [27].
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Fig. 2 Myelopoiesis and neutrophil differentiation in the bone
marrow, showing the consecutive appearance of granules and their
contents
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by neutropenia sets it apart from the above-mentioned
diseases. A rare combined immunodeficiency disorder,
referred to as WHIM syndrome, is characterized by
disseminated human papillomavirus-induced warts, hypo-
gammaglobulinemia, recurrent bacterial infections (immu-
nodeficiency), and myelokathexis, a form of neutropenia
caused by an abnormal retention (i.e., kathexis in old
Greek) of mature neutrophils in the bone marrow. Analysis
of the bone marrow aspirate distinguishes myelokathexis
from other causes of neutropenia.
It is not known which factors exactly cause egress of
blood cells from the bone marrow under normal conditions.
Evidence suggests that protease release by neutrophils in
the bone marrow may play a role. Cases of WHIM
syndrome have been linked to autosomal dominant gain
of function mutations in the gene encoding CX chemokine
receptor 4, resulting in hyperresponsiveness to its ligand
stromal-derived factor 1 leading to decreased motility [10].
Neutropenia in childhood can also be one of the symptoms
of various syndromes. Then, it is usually not the presenting or
dominant symptom, but it may lead to severe infections,
against which precautions should be taken.
Functional defects:
1. Neutrophil motility and adhesion
Leukocytes recognize concentration differences in a
gradient of chemotaxins and thus direct their movement
towards the source of these agents, i.e., towards the
inflammatory site. Apart from the ability to move,
binding to endothelial cells is essential for neutrophils
to leave the bloodstream. Movement between or
through endothelial cells is mediated by adhesion
molecules. Further on, neutrophils bind to tissue cells
and extracellular matrix components (Fig. 4). These
interactions are dynamic because in order to move,
after first binding their ligands, adhesion molecules at
“the tail of the movement” subsequently must be able
to detach. By then binding to other ligands at “the front
of the movement,” the neutrophil is able to move on.
Of course, these adhesion molecules and their con-
trolled ability to switch on and off (i.e., get activated
and deactivated) are tightly regulated [19].
Fig. 3 Oral ulceration in a child with severe congenital neutropenia,
who had also suffered from pneumonia and recurrent otitis
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Fig. 4 Neutrophil motility. Activation of endothelial cells leads to
rolling of neutrophils in the blood circulation along the endothelial
cell lining, mediated by adhesion molecules called selectins, and their
sugar ligands. This results in firm adhesion, mediated by the family of
adhesion molecules called integrins. These steps are essential for the
subsequent migration of neutrophils, between the endothelial cells,
towards the inflammatory focus in the tissues beneath. Absence of
these adhesion molecules in LAD2 (selectin ligands) and LAD1 (β2
integrins) leads to immunodeficiency because otherwise normal
neutrophils are unable to leave the blood stream and reach the
inflammatory site
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microorganisms and the host complement system [the
split product of activated C5 (C5a)]. In addition, lipid
mediators, such as leukotriene B4 and platelet-
activating factor, are also strong chemoattractants. For
each of these agents, receptors are present on neutro-
phils. Furthermore, interleukin-8, a member of chemo-
kine superfamily family of leukocyte activators, is a
powerful chemoattractant and activator for neutrophils.
Small GTPases of the Rho family, in particular Rac-
2 in neutrophils, have been shown to be crucial in the
signaling leading to cytoskeletal remodeling and cellu-
lar motility. This is exemplified by an extremely rare
defect in chemotaxis, ROS production, and degranula-
tion in neutrophils of patients with Rac2 deficiency [1].
Firm adhesion is severely compromised in neutrophils
lacking expression of the β2 integrin chain, leading to
complete absence of an important family of adhesion
molecules, the β2 integrins. The classical adhesion
deficiency is called LAD1, caused by mutations in the
gene encoding the common β2 subunit. In this disease,
otherwise structurally normal neutrophils are not able to
attach to endothelial cells and are thus retained in the
bloodstream. It is characterized by delayed separation of
the umbilical cord followed by an often fatal omphalitis.
The blood count shows an extremely high number of
neutrophils, sometimes prompting physicians to first
consider infant leukemia [11].
Whereas β2 integrins are essential for firm binding
and attachment, other adhesion molecules are needed to
initiate contact between neutrophils and endothelial cells,
leading to “rolling” on the endothelial cell lining. This is
an essential step prior to firm adhesion. In LAD2, this
process is disturbed. It is caused by absence of the SLeX
oligosaccharide, the ligand for interaction with adhesion
molecules of the selectin family on the leukocyte. This
causes a marked decrease in chemotaxis accompanied by
pronounced neutrophilia. Apart from the leukocyte
defect, these patients suffer from severe mental retarda-
tion and stunted growth and exhibit the rare Bombay
blood group type. Infections are but one of the
prominent characteristics of this syndrome [12].
LAD3 or LAD1 variant is characterized by the
combination of a relatively mild LAD phenotype and
platelet dysfunction in the presence of normal integrin
expression. An extensive study of several families with
individuals presenting with this phenotype showed
mutations in the gene FERMT3, encoding a hematopoi-
etic structural protein called Kindlin-3 that acts as a
switch to activate integrins [18, 22].
2. Sensing danger
Toll-like receptors (TLRs) are proteins that play a
key role in the innate immune system. They are
receptors for structurally conserved molecules derived
from microbes. Once these microbes have entered the
body, they are recognized by TLRs which activate
immune cell responses.
Neutrophils express all TLRs, except TLR3 and
TLR7 [14, 23]. Most TLR family members share a
signaling motif called TIR domain, which is responsi-
ble for activation and/or translocation of a pivotal
nuclear transcription factor NF-κB. This is an essential
signaling pathway leading to secretion of IL-1β and
TNFα thus initiating the inflammatory response.
Further downstream, all TLRs signal through MyD88
and Mal, which interact with various IL-1 receptor-
associated kinases (IRAKs).
These data have been substantiated in neutrophils
from children with recurrent pyogenic infections,
especially by Streptocccus pneumoniae, caused by an
inherited IRAK4 deficiency [23]. These patients, once
they have survived early childhood, tend to recover
during adolescence. It is hypothesized that this is
related to maturation of the humoral response which
renders the innate response to streptococcal infections
mediated by IRAK4 redundant. A clinically identical
phenotype as reported for IRAK4 deficiency is seen in
rare patients with autosomal recessively inherited
mutations in the gene encoding MyD88 [4].
3. Killing mechanisms
Phagocytosis is the initial step which allows neu-
trophils to destroy an invasive pathogen. In order to be
phagocytosed, a pathogen needs to be opsonised.
Immunoglobulins, which bind specifically to their
antigens, and complement factors, which bind aspecifi-
cally to conserved microbial motifs, provide an anchor
for their respective receptors on the neutrophil surface.
After phagocytosis, the process of pathogen killing
starts immediately. The combined activity of an active
enzyme complex that is able to produce toxic oxygen
radicals as well as the release of various lytic proteins
which are stored in the granules (elastase, cathepsin G,
defensins) are required to eliminate invading pathogens
[13] (Fig. 5).
Chronic granulomatous disease (CGD) is the most
frequent disorder of neutrophil function. In CGD,
components of an enzyme complex named NADPH
oxidase are absent, which leads to an inability to kill
phagocytosed microorganisms. Apart from fulminant
infections by bacteria and fungi, this also leads to
chronic, low-grade inflammatory reactions character-
ized by granuloma formation. In the gut, this process is
indistinguishable from Crohn's disease, in the lung
CGD that can mimic sarcoidosis [25] (Fig. 6).
The NADPH oxidase complex is composed of two
subunits in the plasma membrane (flavocytochrome
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activity-regulating proteins (p40-phox, p47-phox, and
p67-phox) which form a complex in the cytosol of
resting cells that unfolds upon neutrophil activation
[20]. At the same time, the small Rac GTPase is also
activated [1].
Only when all these components interact, the specific
NADPH-binding site in gp91-phox becomes available
for NADPH from the cytosol. Then and only then,
superoxide (O2
−) is generated. NADPH donates elec-
trons, which are passed on within gp91-phox to
molecular oxygen in the phagosome, thus generating
superoxide. Superoxide spontaneously dismutates into
hydrogen peroxide (H2O2), which may then react with
chloride ions to form hypochlorous acid (bleach), in a
reaction catalyzed by myeloperoxidase. This enzyme is
an abundant constituent of neutrophil azurophil granules
and is released upon cell activation into the phagosome.
Genetically, we can distinguish X-linked CGD, with
mutations in CYBB, the gene that encodes gp91-phox,
and the less common autosomal recessive form of CGD,
with mutations in any of the other NADPH oxidase
components. The autosomal recessive form is character-
ized by better survival [25].
Killing in neutrophils is also impaired in patients with
an abnormal formation of granules. This is the case in
Chédiak–Higashi Syndrome (CHS), in which granule
formation in many granule-containing cells is disturbed
because of mutations in the LYST gene, which encodes a
protein essential for lysosomal trafficking. One of the
hallmarks of CHS is the presence of giant inclusion
bodies seen in neutrophils in a blood smear, reflecting
abnormal granule formation in these cells. However,
neutrophil dysfunction in CHS is not a dominant feature.
Partial albinism may point to the diagnosis, but abnormal
function of cytotoxic T cells leading to uncontrolled
inflammatory responses and lethal hemophagocytosis is
by far the most important feature of this disease [15].
Another extremely rare disorder of neutrophil killing
is neutrophil-specific granule deficiency (SGD). Neutro-
phils from SGD patients lack secondary and tertiary
granules. Gene-inactivating mutations in the C/EBPep-
silon gene have been identified in two SGD patients.
The protein encoded by this gene plays an essential role
in granule formation in myeloid cells [16].
Concluding remarks and treatment options
Once recruited, neutrophils have a wide range of toxic
mechanisms to fight any invading microorganism. In case
of severe congenital neutropenia, the clinician will face the
question whether antibiotic prophylaxis and adequate
treatment once the patient is infected is enough to protect
Fig. 6 Two granulomatous lesions in the thymus of an X-linked CGD
patient
Fig. 5 Neutrophil killing. A
microorganism is opsonized
with immunoglobulins and
complement and thus recog-
nized by a neutrophil. The
pathogen is then engulfed
(phagocytosis) and is digested
within the phagosome by lytic
enzymes stored in the neutro-
phil's granules and toxic oxygen
radicals formed by the NADPH
oxidase
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quently and severely impair the quality of life of a patient,
support of neutrophil development by G-CSF can be
started by subcutaneous administration every other day or
daily when the neutrophil output of the bone marrow is
insufficient. In some of these syndromes, there is a risk of
leukemia, often independent of the use of G-CSF itself.
When the use of high G-CSF doses is necessary to get a
sufficient neutrophil count, the chance of AML accumu-
latively increases in the long term. Careful monitoring of
genetic changes may help to define the moment of
(preemptive) stem cell transplantation.
Antibiotic and/or antifungal prophylaxis is a good
strategy to prevent frequent bacterial infections in neutro-
penia and neutrophil dysfunction. The use of cotrimoxazole
prophylaxis has become the mainstay in CGD and may also
be sufficient in cases of neutropenia [25]. During fulminant
infections that do not respond to antibiotics or antifungals,
transfusion of non-HLA-matched donor neutrophils is a
good option [24].
As the outcome of stem cell transplantation has
considerably improved over the decades, it is increasingly
performed in SCN and functional neutrophil disorders.
Most experts agree that stem cell transplantation in these
diseases should be seriously considered in every patient,
preferably at an early age [7, 21].
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